FDA Approves First Non-Opioid Painkiller in Over Two Decades

Following its recent FDA approval, people are expected to take two pills of Journavx daily, which represents a cost of $31

It's the first non-opiate drug on the market in 25 years. The drug works through a new mechanism of action, and could be a huge step forward in addressing the opioid crisis. The bad news is that it's much more expensive than opiates.

Vertex Pharmaceuticals obtained U.S. approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have been associated with hundreds of thousands of deaths.The Vertex pill, called Journavx, obtained authorization from the Food and Drug Administration to treat acute pain from moderate to severe, according to a Thursday statement. The wholesale purchase cost for the drug t…

FDA Approves First New Non-Opioid Pain Reliever in Decades

The FDA has given the green light to a new non-opioid medication called Journavx, intended for managing moderate-to-severe acute pain in adults. This is the first approval of its kind in over two decades, marking a significant development in pain management. Produced by Vertex Pharmaceuticals, Journavx works by blocking pain signals in the peripheral nervous

FDA approves non-opioid painkiller, first new class in decades

The FDA approved the first new class of non-opioid painkillers in more than two decades, the agency said Thursday. Suzetrigine, branded as Journavx, works to block receptors before they reach the brain in patients with surgical or injury pain.

FDA approves first non-opioid pain medicine in more than 20 years

The drug, Journavx (suzetrigine), inhibits an ion channel in peripheral nerves.